16 results on '"Lonati, Chiara"'
Search Results
2. Genitourinary manifestations of Lynch syndrome in the urological practice
- Author
-
Lonati, Chiara, Simeone, Claudio, Suardi, Nazareno, Spiess, Philippe E., Necchi, Andrea, and Moschini, Marco
- Published
- 2022
- Full Text
- View/download PDF
3. Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration
- Author
-
Lonati, Chiara, Baumeister, Philipp, Afferi, Luca, Mari, Andrea, Minervini, Andrea, Krajewski, Wojciech, Azizi, Sosan, Hendricksen, Kees, Martini, Alberto, Necchi, Andrea, Montorsi, Francesco, Briganti, Alberto, Colombo, Renzo, Tafuri, Alessandro, Antonelli, Alessandro, Cerruto, Maria Angela, Rouprêt, Morgan, Masson-Lecomte, Alexandra, Laukhtina, Ekaterina, D’Andrea, David, Shariat, Shahrokh F., Soria, Francesco, Marra, Giancarlo, Gontero, Paolo, Contieri, Roberto, Hurle, Rodolfo, Valiquette, Anne Sophie, Mir, M. Carmen, Zamboni, Stefania, Simeone, Claudio, Klatte, Tobias, Teoh, Jeremy Yuen-Chun, Yoshida, Soichiro, Fujii, Yasuhisa, Carando, Roberto, Schulz, Gerald B., Mordasini, Livio, Mattei, Agostino, and Moschini, Marco
- Published
- 2022
- Full Text
- View/download PDF
4. Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma
- Author
-
Martini, Alberto, Lonati, Chiara, Nocera, Luigi, Fallara, Giuseppe, Raggi, Daniele, Herout, Roman, Zamboni, Stefania, Ploussard, Guillaume, Predere, Benjamin, Mattei, Agostino, Simeone, Claudio, Krajewski, Wojciech, Simone, Giuseppe, Soria, Francesco, Gontero, Paolo, Roupret, Morgan, Montorsi, Francesco, Briganti, Alberto, Shariat, Shahrokh F., Necchi, Andrea, and Moschini, Marco
- Published
- 2022
- Full Text
- View/download PDF
5. Retroperitoneal Robot-assisted Partial Nephrectomy: A Systematic Review and Pooled Analysis of Comparative Outcomes
- Author
-
Carbonara, Umberto, Crocerossa, Fabio, Campi, Riccardo, Veccia, Alessandro, Cacciamani, Giovanni E., Amparore, Daniele, Checcucci, Enrico, Loizzo, Davide, Pecoraro, Angela, Marchioni, Michele, Lonati, Chiara, Sundaram, Chandru P., Mehrazin, Reza, Porter, James, Kaouk, Jihad H., Porpiglia, Francesco, Ditonno, Pasquale, and Autorino, Riccardo
- Published
- 2022
- Full Text
- View/download PDF
6. Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy
- Author
-
Lonati, Chiara, Baumeister, Philipp, Ornaghi, Paola Irene, Di Trapani, Ettore, De Cobelli, Ottavio, Rink, Michael, Karnes, Robert Jeffrey, Poyet, Cédric, Simone, Giuseppe, Afferi, Luca, Necchi, Andrea, Briganti, Alberto, Montorsi, Francesco, Krajewski, Wojciech, Antonelli, Alessandro, Cerruto, Maria Angela, Zamboni, Stefania, Simeone, Claudio, Mordasini, Livio, Mattei, Agostino, and Moschini, Marco
- Published
- 2022
- Full Text
- View/download PDF
7. Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors
- Author
-
Lonati, Chiara, Necchi, Andrea, Gómez Rivas, Juan, Afferi, Luca, Laukhtina, Ekaterina, Martini, Alberto, Ventimiglia, Eugenio, Colombo, Renzo, Gandaglia, Giorgio, Salonia, Andrea, Briganti, Alberto, Montorsi, Francesco, Mattei, Agostino, Simeone, Claudio, Carlo, Maria I., Shariat, Shahrokh F., Spiess, Philippe E., and Moschini, Marco
- Published
- 2022
- Full Text
- View/download PDF
8. Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer
- Author
-
Afferi, Luca, Lonati, Chiara, Montorsi, Francesco, Briganti, Alberto, Necchi, Andrea, Mari, Andrea, Minervini, Andrea, Tellini, Riccardo, Campi, Riccardo, Schulz, Gerald Bastian, Black, Peter C., di Trapani, Ettore, de Cobelli, Ottavio, Karnes, R. Jeffrey, Ahmed, Mohamed, Mir, M. Carmen, Algarra, Maria Asuncion, Rink, Michael, Zamboni, Stefania, Mondini, Francesca, Simeone, Claudio, Antonelli, Alessandro, Tafuri, Alessandro, Krajewski, Wojciech, Małkiewicz, Bartosz, Xylinas, Evanguelos, Soria, Francesco, Sanchez Salas, Rafael, Arora, Amandeep, Cathelineau, Xavier, Hendricksen, Kees, Ammiwala, Maida, Borghesi, Marco, Chierigo, Francesco, Teoh, Jeremy Yuen-Chun, Mattei, Agostino, Albisinni, Simone, Roghmann, Florian, Roumiguié, Mathieu, Bajeot, Anne Sophie, Maier, Elisabeth, Aziz, Atiqullah, Hurle, Rodolfo, Contieri, Roberto, Pradere, Benjamin, Carando, Roberto, Poyet, Cedric, Alvarez-Maestro, Mario, D'Andrea, David, Shariat, Shahrokh F., and Moschini, Marco
- Published
- 2022
- Full Text
- View/download PDF
9. Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival.
- Author
-
Martini, Alberto, Lonati, Chiara, Necchi, Andrea, Galsky, Matthew D., Ploussard, Guillaume, Fallara, Giuseppe, Pellegrino, Antony, Simeone, Claudio, Suardi, Nazareno, Zamboni, Stefania, Krajewski, Wojciech, Simone, Giuseppe, Briganti, Alberto, Montorsi, Francesco, Mattei, Agostino, Shariat, Shahrokh F., and Moschini, Marco
- Subjects
- *
OVERALL survival , *METASTASIS , *TRANSITIONAL cell carcinoma , *TERTIARY care , *CONFIDENCE intervals - Abstract
Intermediate clinical endpoints (ICE) help expedite approval of novel treatments. We aimed to identify the most informative ICE for predicting overall survival (OS) after radical nephroureterectomy (RNU) for high-grade upper tract urothelial carcinoma. Distant metastases within 3-years from RNU are the most effective surrogates of OS after RNU and could be useful to expedite earlier results of future studies. Introduction: The only phase III trial that evaluated the role of adjuvant chemotherapy following radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) was terminated early. Thus, eventual overall survival (OS) surrogacy, as per Prentice, cannot be assessed in this setting. We aimed to identify an intermediate clinical endpoint (ICE) that could serve as an OS surrogate after RNU for UTUC. Patients and Methods: We retrospectively analyzed 823 high-grade UTUC patients treated with RNU at 8 tertiary referral centers. We explored the role of any recurrence (aR), defined as recurrence in the urinary tract or in the resection bed as well the presence of distant metastasis (DM), defined as metastatic disease outside the urinary tract and regional lymph nodes, on OS through a time-varying Cox regression analyses fitted at the landmark points of 1, 2, 3, and 4 years from RNU. Models' discrimination was assessed using Harrell's c index, after internal validation. Results: Median follow-up for survivors was 5.6 years (interquartile range: 2.0-8.8). Overall, 391 and 212 patients experienced aR and DM, respectively. In a time-varying model, aR and DM were predictors of OS: hazard ratio [HR]:1.20, 95% confidence interval [CI]: 1.13-1.28 (P < .001) and HR:1.26, 95% CI: 1.18-1.34 (P < .001), respectively. Progression to DM within 3 years from RNU was the most informative ICE for predicting OS (c index: 0.81; HR: 4.40; 95%CI: 2.45-7.92; P < .001), compared to DM within 1, 2, and 4 years (c indexes: 0.74, 0.76, and 0.78, respectively). Progression to DM within 3 years from RNU was further found superior for predicting OS compared to aR at any landmark points. Conclusions: Progression to DM within 3 years represents a potential OS surrogate for surgicallytreated UTUC. This information could help in patient counseling, future study design and expedite results release of ongoing randomized controlled trials. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy.
- Author
-
Martini, Alberto, Lonati, Chiara, Montorsi, Francesco, Briganti, Alberto, Colombo, Renzo, Necchi, Andrea, Simeone, Claudio, Zamboni, Stefania, Afferi, Luca, Mattei, Agostino, Carando, Roberto, Ploussard, Guillaume, Soria, Francesco, Marra, Giancarlo, Rouprêt, Morgan, Xylinas, Evanguelos, Pradere, Benjamin, Abufaraj, Mohammad, D'Andrea, David, and Shariat, Shahrokh F.
- Subjects
- *
BLADDER cancer treatment , *CANCER relapse , *MEDICAL decision making , *LYMPH nodes , *BLADDER cancer patients - Abstract
The prognostic role of prior bladder cancer (BCa) among upper tract urothelial carcinoma (UTUC) patients is still poorly addressed. We retrospectively analyzed a multicenter cohort of 1,580 patients to assess the role of prior BCa on any recurrence after radical nephroureterectomy for UTUC. Our findings show that patients with prior BCa history exhibit a significantly increased risk of any recurrence. Introduction: The prognostic role of prior history of bladder cancer (BCa) among patients treated with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) is poorly addressed. We aimed to investigate the role of prior BCa on any recurrence, distant metastases, and bladder recurrence following RNU among low-grade (LG) and high-grade (HG) UTUC patients. Patients and Methods: We retrospectively analyzed 1,580 UTUC patients treated with RNU at 8 tertiary referral centers between 1992 and 2016. Any recurrence was defined as recurrence in the urinary tract, in the resection bed, or distant metastases (defined as disease outside the urinary tract and regional lymph nodes). Time to recurrence was computed from RNU. Multivariable Cox models were generated to predict risk of any recurrence, distant metastases, and bladder recurrence according to prior BCa history, coded as no prior BCa, non-muscle-invasive (NMIBC), and muscle-invasive BCa (MIBC). Results: Median follow-up for survivors was 4 years. Overall, 71%, 25%, and 4% of patients had no prior BCa, NMIBC and MIBC. 5-year any recurrence-free survival was 61%, 41%, and 19% in LG (P < .001) and 42%, 34%, and 30% in HG patients (P = .1) with no prior BCa, NMIBC, and MIBC. On multivariable models, LG patients with NMIBC and MIBC showed a significantly higher risk of any recurrence compared to no prior BCa (both p =0.005); previous NMIBC was associated with any recurrence among HG patients (P = 0.04). 5-year distant metastases-free survival was 92%, 90%, and 87% in LG (P > .05) and 68%, 75%, and 45% in HG patients (P = .01) with no prior BCa, NMIBC, and MIBC. Previous NMIBC increased the risk of bladder recurrence among LG (P < .001) and HG (P = .003) patients. Conclusions: UTUC patients with prior history of BCa exhibit a higher risk of any recurrence after RNU. Our study provides important information which could address patient's counseling and decision-making process. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study.
- Author
-
Grossmann, Nico C., Pradere, Benjamin, D'Andrea, David, Schuettfort, Victor M., Keiichiro Mori, Rajwa, Pawel, Quhal, Fahad, Laukhtina, Ekaterina, Satoshi Katayama, Fankhauser, Christian D., Xylinas, Evanguelos, Margulis, Vitaly, Moschini, Marco, Abufaraj, Mohammad, Bandini, Marco, Lonati, Chiara, Nyirady, Peter, Karakiewicz, Pierre I., Fajkovic, Harun, and Shariat, Shahrokh F.
- Subjects
NEOADJUVANT chemotherapy ,TRANSITIONAL cell carcinoma ,URINARY organ cancer treatment ,CISPLATIN ,DOXORUBICIN - Abstract
This study evaluated elderly patients receiving neoadjuvant chemotherapy for upper tract urothelial carcinoma. Compared with their younger counterparts, cisplatin-eligible elderly patients showed similar pathologic response rates and survival outcomes. Cisplatin-ineligible elderly patients appeared to have lower pathologic response rates and might be therefore more likely to benefit from immediate radical nephroureterectomy. Introduction: Although upper tract urothelial carcinoma (UTUC) is more common in the elderly, outcomes of neoadjuvant chemotherapy (NAC) in this population have never been explored. The objective of the study was to assess the impact of NAC on pathologic response and oncological outcomes stratified by age. Patients and Methods: This multicenter study included 164 patients treated with NAC and radical nephroureterectomy (RNU) for clinically non-metastatic, high-risk UTUC. The cohort was stratified into two groups according to median age. Patients received either cisplatinbased or non-cisplatin-based chemotherapies. Pathologic responses were defined as pathologic objective response (pOR; = ypT1N0) and pathologic complete response (pCR; ypT0N0). Univariable and multivariable logistic and Cox regression analyses were performed to identify predictors for pathologic response and survival outcomes. Results: The cohorts' median age was 68 years with the elderly group (> 68 years) comprising 74 patients. Neoadjuvant chemotherapy included methotrexate-vinblastine-doxorubicin-cisplatin (MVAC) in 66 (40%), gemcitabine cisplatin (GC) in 66 (40%) and non-cisplatin chemotherapy in 32 patients (20%). Younger patients received more often MVAC (50% vs. 28%) while elderly received more GC (34% vs. 47%) or non-cisplatin chemotherapy (16% vs. 24%) (P = .02). Overall, pOR and pCR were similar across age groups (52% vs. 47%; P = .5 and 10% vs. 8%; P = .7). While GC and non-cisplatin chemotherapy showed a lower pCR of 5% and 3%, respectively, MVAC revealed a pCR of 17% (P = .03) and was independently associated with a higher pCR (OR 4.31; P = .03). Kaplan-Meier analysis showed no difference in recurrence-free and cancer-specific survival, whereas a lower rate was seen in overall survival for the elderly. Conclusion: Elderly patients with high-risk UTUC eligible for cisplatin-based NAC prior to RNU may benefit from this multimodal therapy equally as their younger counterparts. Cisplatin-ineligible patients undergoing non-cisplatin-based NAC appeared to have lower response rates and should be considered for immediate RNU. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients
- Author
-
Mannucci, Pier Mannuccio, Nobili, Alessandro, Pietrangelo, Antonello, Perticone, Francesco, Licata, Giuseppe, Violi, Francesco, Corazza, Gino Roberto, Corrao, Salvatore, Marengoni, Alessandra, Salerno, Francesco, Cesari, Matteo, Tettamanti, Mauro, Pasina, Luca, Franchi, Carlotta, Cortesi, Laura, Miglio, Gabriella, Ardoino, Ilaria, Novella, Alessio, Prisco, Domenico, Silvestri, Elena, Emmi, Giacomo, Bettiol, Alessandra, Caterina, Cenci, Biolo, Gianni, Zanetti, Michela, Guadagni, Martina, Zaccari, Michele, Chiuch, Massimiliano, Vanoli, Massimo, Grignani, Giulia, Pulixi, Edoardo Alessandro, Bernardi, Mauro, Bassi, Silvia Li, Santi, Luca, Zaccherini, Giacomo, Lupattelli, Graziana, Mannarino, Elmo, Bianconi, Vanessa, Paciullo, Francesco, Alcidi, Riccardo, Nuti, Ranuccio, Valenti, Roberto, Ruvio, Martina, Cappelli, Silvia, Palazzuoli, Alberto, Girelli, Domenico, Busti, Fabiana, Marchi, Giacomo, Barbagallo, Mario, Dominguez, Ligia, Cocita, Floriana, Beneduce, Vincenza, Plances, Lidia, Natoli, Giuseppe, Mularo, Salvatore, Raspanti, Massimo, Cavallaro, Federica, Zoli, Marco, Lazzari, Ilaria, Brunori, Mattia, Fabbri, Elisa, Magalotti, Donatella, Arnò, Raffaella, Pasini, Franco Laghi, Capecchi, Pier Leopoldo, Palasciano, Giuseppe, Modeo, Maria Ester, Gennaro, Carla Di, Cappellini, Maria Domenica, Maira, Diletta, Di Stefano, Valeria, Fabio, Giovanna, Seghezzi, Sonia, Mancarella, Marta, De Amicis, Margherita Migone, De Luca, Giacomo, Scaramellini, Natalia, Rossi, Paolo Dionigi, Damanti, Sarah, Clerici, Marta, Conti, Federica, Bonini, Giulia, Ottolini, Barbara Brignolo, Di Sabatino, Antonio, Miceli, Emanuela, Lenti, Marco Vincenzo, Pisati, Martina, Dominioni, Costanza Caccia, Murialdo, Giovanni, Marra, Alessio, Cattaneo, Federico, Pontremoli, Roberto, Beccati, Valentina, Nobili, Giulia, Secchi, Maria Beatrice, Ghelfi, Davide, Anastasio, Luigi, Sofia, Lucia, Carbone, Maria, Cipollone, Francesco, Guagnano, Maria Teresa, Valeriani, Emanuele, Rossi, Ilaria, Mancuso, Gerardo, Calipari, Daniela, Bartone, Mosè, Delitala, Giuseppe, Berria, Maria, Pes, Chiara, Delitala, Alessandro, Muscaritoli, Maurizio, Molfino, Alessio, Petrillo, Enrico, Zuccalà, Giuseppe, D’Aurizio, Gabriella, Romanelli, Giuseppe, Zucchelli, Alberto, Manzoni, Francesca, Volpini, Andrea, Picardi, Antonio, Gentilucci, Umberto Vespasiani, Gallo, Paolo, Dell’Unto, Chiara, Annoni, Giorgio, Corsi, Maurizio, Bellelli, Giuseppe, Zazzetta, Sara, Mazzola, Paolo, Szabo, Hajnalka, Bonfanti, Alessandra, Arturi, Franco, Succurro, Elena, Rubino, Mariangela, Tassone, Bruno, Sesti, Giorgio, Interna, Medicina, Serra, Maria Grazia, Bleve, Maria Antonietta, Gasbarrone, Laura, Sajeva, Maria Rosaria, Brucato, Antonio, Ghidoni, Silvia, Fabris, Fabrizio, Bertozzi, Irene, Bogoni, Giulia, Rabuini, Maria Victoria, Cosi, Elisabetta, Scarinzi, Paolo, Amabile, Annalisa, Omenetto, Elisabetta, Prandini, Tancredi, Manfredini, Roberto, Fabbian, Fabio, Boari, Benedetta, Giorgi, Alfredo De, Tiseo, Ruana, De Giorgio, Roberto, Paolisso, Giuseppe, Rizzo, Maria Rosaria, Borghi, Claudio, Strocchi, Enrico, Ianniello, Eugenia, Soldati, Mario, Sabbà, Carlo, Vella, Francesco Saverio, Suppressa, Patrizia, Schilardi, Andrea, Loparco, Francesca, De Vincenzo, Giovanni Michele, Comitangelo, Alessio, Amoruso, Emanuele, Fenoglio, Luigi, Falcetta, Andrea, Bracco, Christian, Fracanzani, Anna L., Fargion, Silvia, Tiraboschi, Silvia, Cespiati, Annalisa, Oberti, Giovanna, Sigon, Giordano, Peyvandi, Flora, Rossio, Raffaella, Ferrari, Barbara, Colombo, Giulia, Agosti, Pasquale, Monzani, Valter, Savojardo, Valeria, Folli, Christian, Ceriani, Giuliana, Pallini, Giada, Dallegri, Franco, Ottonello, Luciano, Liberale, Luca, Caserza, Lara, Salam, Kassem, Liberato, Nicola Lucio, Tognin, Tiziana, Bianchi, Giovanni Battista, Giaquinto, Sabrina, Purrello, Francesco, Di Pino, Antonino, Piro, Salvatore, Rozzini, Renzo, Falanga, Lina, Spazzini, Elena, Ferrandina, Camillo, Montrucchio, Giuseppe, Petitti, Paolo, Peasso, Paolo, Favale, Edoardo, Poletto, Cesare, Salmi, Raffaella, Gaudenzi, Piergiorgio, Perri, Ludovica, Landolfi, Raffaele, Montalto, Massimo, Mirijello, Antonio, Guasti, Luigina, Castiglioni, Luana, Maresca, Andrea, Squizzato, Alessandro, Campiotti, Leonardo, Grossi, Alessandra, Bertolotti, Marco, Mussi, Chiara, Lancellotti, Giulia, Libbra, Maria Vittoria, Dondi, Giulia, Pellegrini, Elisa, Carulli, Lucia, Galassi, Matteo, Grassi, Yasmine, Perticone, Maria, Battaglia, Rosa, FIlice, Marco, Maio, Raffaele, Stanghellini, Vincenzo, Ruggeri, Eugenio, del Vecchio, Sara, Salvi, Andrea, Leonardi, Roberto, Damiani, Giampaolo, Capeci, William, Gabrielli, Armando, Mattioli, Massimo, Martino, Giuseppe Pio, Biondi, Lorenzo, Pettinari, Pietro, Ghio, Riccardo, Col, Anna Dal, Minisola, Salvatore, Colangelo, Luciano, Cilli, Mirella, Labbadia, Giancarlo, Afeltra, Antonella, Marigliano, Benedetta, Pipita, Maria Elena, Castellino, Pietro, Zanoli, Luca, Pignataro, Samuele, Gennaro, Alfio, Blanco, Julien, Saracco, Valter, Fogliati, Marisa, Bussolino, Carlo, Mete, Francesca, Gino, Miriam, Cittadini, Antonio, Vigorito, Carlo, Arcopinto, Michele, Salzano, Andrea, Bobbio, Emanuele, Marra, Alberto Maria, Sirico, Domenico, Moreo, Guido, Gasparini, Francesca, Prolo, Silvia, Pina, Gloria, Ballestrero, Alberto, Ferrando, Fabio, Berra, Sergio, Dassi, Simonetta, Nava, Maria Cristina, Graziella, Bruno, Baldassarre, Stefano, Fragapani, Salvatore, Gruden, Gabriella, Galanti, Giorgio, Mascherini, Gabriele, Petri, Cristian, Stefani, Laura, Girino, Margherita, Piccinelli, Valeria, Nasso, Francesco, Gioffrè, Vincenza, Pasquale, Maria, Scattolin, Giuseppe, Martinelli, Sergio, Turrin, Mauro, Sechi, Leonardo, Catena, Cristina, Colussi, Gianluca, Passariello, Nicola, Rinaldi, Luca, Berti, Franco, Famularo, Giuseppe, Tarsitani, Patrizia, Castello, Roberto, Pasino, Michela, Ceda, Gian Paolo, Maggio, Marcello Giuseppe, Morganti, Simonetta, Artoni, Andrea, Del Giacco, Stefano, Firinu, Davide, Losa, Francesca, Paoletti, Giovanni, Costanzo, Giulia, Montalto, Giuseppe, Licata, Anna, Malerba, Valentina, Montalto, Filippo Alessandro, Lasco, Antonino, Basile, Giorgio, Catalano, Antonino, Malatino, Lorenzo, Stancanelli, Benedetta, Terranova, Valentina, Di Marca, Salvatore, Di Quattro, Rosario, La Malfa, Lara, Caruso, Rossella, Mecocci, Patrizia, Ruggiero, Carmelinda, Boccardi, Virginia, Meschi, Tiziana, Lauretani, Fulvio, Ticinesi, Andrea, Nouvenne, Antonio, Minuz, Pietro, Fondrieschi, Luigi, Pirisi, Mario, Fra, Gian Paolo, Sola, Daniele, Porta, Massimo, Riva, Piero, Quadri, Roberto, Larovere, Erica, Novelli, Marco, Scanzi, Giorgio, Mengoli, Caterina, Provini, Stella, Ricevuti, Laura, Simeone, Emilio, Scurti, Rosa, Tolloso, Fabio, Tarquini, Roberto, Valoriani, Alice, Dolenti, Silvia, Vannini, Giulia, Tedeschi, Alberto, Trotta, Lucia, Volpi, Riccardo, Bocchi, Pietro, Vignali, Alessandro, Harari, Sergio, Lonati, Chiara, Cattaneo, Mara, Napoli, Federico, Carlotta, Franchi, Raffaella, Rossio, Ilaria, Ardoino, Alessandro, Nobili, and Mannuccio, Mannucci Pier
- Published
- 2019
- Full Text
- View/download PDF
13. Re: Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study
- Author
-
Lonati, Chiara and Suardi, Nazareno
- Published
- 2022
- Full Text
- View/download PDF
14. Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?
- Author
-
Cimadamore, Alessia, Lonati, Chiara, Di Trapani, Ettore, De Cobelli, Ottavio, Rink, Michael, Zamboni, Stefania, Simeone, Claudio, Soria, Francesco, Briganti, Alberto, Montorsi, Francesco, Afferi, Luca, Mattei, Agostino, Carando, Roberto, Ornaghi, Paola Irene, Tafuri, Alessandro, Antonelli, Alessandro, Karnes, Robert J., Colomer, Anna, Sanchez-Salas, Rafael, and Contieri, Roberto
- Subjects
- *
CYSTECTOMY , *BLADDER , *RETROSPECTIVE studies , *TRANSITIONAL cell carcinoma ,BLADDER tumors - Abstract
Objective: To compare the accuracy in detecting variant histologies (VH) at transurethral resection of bladder (TURB) and radical cystectomy (RC) specimen among tertiary referral centres, in order to investigate potential reasons of discrepancies from the pathological point of view.Patients and Methods: Clinical and histopathological data of TURB specimen and subsequent cystectomy specimen of 3,445 RC candidate patients have been retrospectively collected from 24 tertiary referral centres between 1980 and 2021. VH considered in the analysis were pure squamous cell carcinoma, urothelial carcinoma with squamous differentiation, pure adenocarcinoma, urothelial carcinoma with glandular differentiation, micropapillary bladder cancer (BCa), neuroendocrine BCa, and other variants. The degree of agreement between TURB and RC concerning the identification of VH was expressed as concordance, classified according to Cohen's kappa coefficient.Results: A VH was reported in 17% of TURB specimens, 45% of which were not confirmed in RC. The lowest concordance rate was reported for micropapillary BCa with 11 out of 18 (61%) centres reporting no agreement, whereas neuroendocrine BCa achieved the highest concordance rate with only 3 centres (17%) reporting no agreement. Our results shows that even among centres with the advantage of a referent uropathologist the micropapillary variant is characterized by scarce accuracy between TURB and RC. Differences in TURB specimen acquisition by the urologist and in sampling methods among different centres are the main limitations of the study.Conclusions: Accuracy of TURB in detecting VH is poor for certain VH, in particular for micropapillary BCa, with evident variation among centres. Novel diagnostic tools are required to better identify these VH and drive patients toward a personalized treatment. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
15. Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists.
- Author
-
Lonati, Chiara, Mordasini, Livio, Afferi, Luca, De Cobelli, Ottavio, Di Trapani, Ettore, Necchi, Andrea, Colombo, Renzo, Briganti, Alberto, Montorsi, Francesco, Simeone, Claudio, Zamboni, Stefania, Simone, Giuseppe, Karnes, Robert Jeffrey, Marra, Giancarlo, Soria, Francesco, Gontero, Paolo, Shariat, Shahrokh F., Pradere, Benjamin, Hendricksen, Kees, and Ammiwala, Maida
- Subjects
- *
LYMPH node surgery , *CYSTECTOMY , *RESEARCH , *LYMPHADENECTOMY , *RESEARCH methodology , *LYMPH nodes , *RETROSPECTIVE studies , *EVALUATION research , *TUMOR classification , *COMPARATIVE studies , *UROLOGY ,BLADDER tumors - Abstract
Background: The preoperative lymph node (LN) staging of bladder cancer (BCa) addresses the subsequent therapeutic strategy and influences patient's prognosis. However, sparce evidence exists regarding the accuracy of conventional cross-sectional imaging, such as computed tomography or magnetic resonance imaging, in correctly detect LN status. We aimed to assess the diagnostic accuracy of conventional cross-sectional imaging in detecting preoperative LN involvement among BCa patients treated with radical cystectomy and pelvic lymph node dissection.Methods: We retrospectively analyzed data of 1,104 patients who underwent preoperative LN staging with computed tomography or magnetic resonance imaging and subsequent radical cystectomy with pelvic lymph node dissection for BCa between 1997 and 2017 at three tertiary referral centers. Patients receiving neoadjuvant chemotherapy were excluded. We assessed the concordance between clinical (cN) and pathological LN (pN) status, defined as the accuracy of imaging in detecting LN involvement using pathological specimen as reference; concordance was expressed according to Cohen's kappa coefficient. Location-based sub-analyses were performed, distinguishing among external iliac, intern iliac, obturator, common iliac, presacral and paraaortic LNs.Results: Among 870 cN0 patients, 68.9% were confirmed pN0 at pathological report; while among 234 cN+ patients, 50.5% were found with LN metastases at pathological specimen. Overall, conventional imaging showed slight concordance (64.9%) between cN and pN stages (sensitivity: 30%; specificity: 84%). At sub-analysis, no agreement between cN and pN status was found in each LN location, with the only exception of common iliac LNs with slight concordance (37.5%). Common iliac LNs achieved the highest sensitivity and positive likelihood ratio (15% and 2.4, respectively) compared to other LN locations.Conclusions: Overall, preoperative cross-sectional imaging exhibited a slight concordance between cN and pN status. Our location-based sub-analyses showed unsatisfactory results in each LN location- Thus, nomograms combining morphological patterns with serological and clinicopathological features are urgently required. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
16. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids.
- Author
-
Proietti, Marco, Agosti, Pasquale, Lonati, Chiara, Corrao, Salvatore, Perticone, Francesco, Mannucci, Pier Mannuccio, Nobili, Alessandro, and Harari, Sergio
- Subjects
- *
OBSTRUCTIVE lung disease diagnosis , *RESPIRATORY insufficiency , *CORTICOSTEROIDS , *HOSPITAL care of older people , *BRONCHODILATOR agents , *CARDIOVASCULAR diseases risk factors , *CONFIDENCE intervals , *HOSPITAL admission & discharge , *INTERNAL medicine , *LIFE skills , *LONGITUDINAL method , *OBSTRUCTIVE lung diseases , *MEDICAL cooperation , *MEDICAL protocols , *SCIENTIFIC observation , *PATIENTS , *RESEARCH , *SMOKING , *DISCHARGE planning , *TREATMENT effectiveness , *DISEASE prevalence , *DISEASE exacerbation , *POLYPHARMACY , *INHALATION administration , *ODDS ratio , *OLD age , *DISEASE risk factors - Abstract
We aimed to analyze the prevalence and impact of COPD in older patients hospitalized in internal medicine or geriatric wards, and to investigate adherence to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, associated clinical factors, and outcomes. Data were obtained from REgistro POliterapie SIMI (REPOSI), a prospective multicenter observational registry that enrolls inpatients aged ≥65 years. Older hospitalized patients enrolled from 2008 to 2016 with a diagnosis of COPD. We evaluated adherence to the 2018 GOLD guidelines at admission and discharge, by examining the prescription of inhaled bronchodilators and corticosteroids in COPD patients. We also evaluated the occurrence of outcomes and its association with COPD and guideline adherence. At hospital admission, COPD was diagnosed in 1302 (21.5%) of 6046 registered patients. COPD patients were older, with more impaired clinical and functional status and multiple comorbidities. Overall, 34.3% of COPD patients at admission and 35.6% at discharge were adherent to the GOLD guidelines. Polypharmacy (≥5 drugs) at admission [odds ratio (OR): 3.28, 95% confidence interval (CI): 2.24-4.81], a history of acute COPD exacerbation (OR: 2.65, 95% CI: 1.44-4.88) at admission, smoking habit (OR: 1.45, 95% CI: 1.08-1.94), and polypharmacy at discharge (OR: 6.76, 95% CI: 4.15-11.0) were associated with adherence to guidelines. COPD was independently associated with the risk of cardiovascular and respiratory death and rehospitalization occurrence compared to patients without COPD during follow-up. Adherence to guidelines was inversely associated with the occurrence of death from all causes (OR: 0.12, 95% CI: 0.02-0.90). COPD was common in older patients acutely hospitalized, showing an impaired functional and clinical status. Prescriptions for older COPD patients were often not adherent to GOLD guidelines. Poor adherence to guidelines was associated with a worse clinical status. There is a need to improve adherence to guidelines in treating COPD patients, with the ultimate goal of reducing clinical events. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.